A study performed by Clavel et al., investigated various angiogenesis markers, VEGF, angiopoietin-1 (Ang-1), and soluble Fms-like tyrosine kinase-1 (sFlt-1) in patients with very early arthritis, in order to assess their relevance for predicting subsequent joint destruction. This evidence concerns the gene FLT1 and arthritic joint disease.